Rodriguez-Palacios, AlexanderHarding, AndrewMenghini, PaolaHimmelman, CatherineRetuerto, MauricioNickerson, Kourtney P.Lam, MinhCroniger, Colleen M.McLean, Mairi HDurum, Scott KPizarro, Theresa TGhannoum, Mahmoud AIlic, SanjaMcDonald, ChristineCominelli, Fabio2019-03-152019-03-152018-05Rodriguez-Palacios, A, Harding, A, Menghini, P, Himmelman, C, Retuerto, M, Nickerson, K P, Lam, M, Croniger, C M, McLean, M H, Durum, S K, Pizarro, T T, Ghannoum, M A, Ilic, S, McDonald, C & Cominelli, F 2018, 'The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn’s Disease–Like Ileitis', Inflammatory Bowel Diseases, vol. 24, no. 5, pp. 1005-1020. https://doi.org/10.1093/ibd/izy0601078-0998ORCID: /0000-0002-7443-2653/work/76974200http://hdl.handle.net/2164/12051We thank John D. Ward and Lindsey N. Kaydo for their technical support and Dr. Wei Xin for the histological scoring of ileitis severity. ARP is an Assistant Professor of Medicine at CWRU School of Medicine. Metagenomic sequencing was conducted in the laboratory of Dr. Skip Virgin at Washington University, School of Medicine, St. Louis, MO. Raw sequencing data files will be available upon request.161126310engCrohn’s diseaseartificial sweetenermyeloperoxidase activityproteobacteriaBacteroidetesR MedicineRThe Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn’s Disease–Like IleitisJournal article10.1093/ibd/izy060245